HCA Healthcare Files Q3 2024 10-Q
Ticker: HCA · Form: 10-Q · Filed: Oct 31, 2024 · CIK: 860730
Sentiment: neutral
Topics: 10-Q, healthcare, financials
TL;DR
HCA Healthcare's Q3 2024 10-Q is in. Financials and operations detailed.
AI Summary
HCA Healthcare, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter. Key financial data and disclosures related to its hospital facilities and outpatient services are included.
Why It Matters
This filing provides investors with an update on HCA Healthcare's financial health and operational performance, crucial for understanding the company's current standing and future prospects in the healthcare sector.
Risk Assessment
Risk Level: medium — The filing contains standard financial disclosures for a large public company, but the healthcare sector can be subject to regulatory and reimbursement risks.
Key Numbers
- 2024-09-30 — Reporting Period End Date (Indicates the end of the fiscal quarter being reported.)
- 2024-10-31 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- HCA Healthcare, Inc. (company) — Filer of the 10-Q
- 20240930 (date) — Conformed period of report
- 20241031 (date) — Filing date
- Nashville, TN (location) — Company headquarters
FAQ
What is the reporting period for this 10-Q filing?
The conformed period of report is 20240930, meaning the filing covers the period up to September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on 20241031.
What is the primary business of HCA Healthcare, Inc. according to the filing?
HCA Healthcare, Inc. is in the SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC industry, SIC code [8062].
What is the company's business address?
The business address is ONE PARK PLZ, NASHVILLE, TN 37203.
Has HCA Healthcare, Inc. had previous names?
Yes, the company was formerly known as HCA Holdings, Inc. (name change 20101126), HCA INC/TN (name change 20010627), and HCA THE HEALTHCARE CO (name change 20010419).
Filing Stats: 4,531 words · 18 min read · ~15 pages · Grade level 11.3 · Accepted 2024-10-31 16:30:23
Filing Documents
- hca-20240930.htm (10-Q) — 2430KB
- hca-ex22.htm (EX-22) — 4KB
- hca-ex31_1.htm (EX-31.1) — 14KB
- hca-ex31_2.htm (EX-31.2) — 15KB
- hca-ex32.htm (EX-32) — 14KB
- 0000950170-24-119581.txt ( ) — 8429KB
- hca-20240930.xsd (EX-101.SCH) — 879KB
- hca-20240930_htm.xml (XML) — 1623KB
Financial Statements (Unaudited)
Financial Statements (Unaudited): Condensed Consolidated Income Statements — for the quarters and nine months ended September 30, 2024 and 2023 3 Condensed Consolidated Comprehensive Income Statements — for the quarters and nine months ended September 30, 2024 and 2023 4 Condensed Consolidated Balance Sheets — September 30, 2024 and December 31, 2023 5 Condensed Consolidated Statements of Stockholders' Equity (Deficit) — for the quarters and nine months ended September 30, 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows — for the nine months ended September 30, 2024 and 2023 7 Notes to Condensed Consolidated Financial Statements 8 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 29 Item 4.
Controls and Procedures
Controls and Procedures 29 Part II. Other Information Item 1.
Legal Proceedings
Legal Proceedings 29 Item 1A.
Risk Factors
Risk Factors 29 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29 Item 5. Other Information 30 Item 6. Exhibits 30
Signatures
Signatures 31 2 HCA HEALTHCARE, INC. CONDENSED CONSOLIDATED INCOME STATEMENTS FOR THE QUARTERS AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023 Unaudited (Dollars in millions, except per share amounts) Quarter Nine Months 2024 2023 2024 2023 Revenues $ 17,487 $ 16,213 $ 52,318 $ 47,665 Salaries and benefits 7,861 7,556 23,253 21,917 Supplies 2,657 2,417 7,962 7,318 Other operating expenses 3,717 3,379 10,946 9,316 Equity in (earnings) losses of affiliates ( 15 ) ( 19 ) ( 13 ) 6 Depreciation and amortization 842 769 2,456 2,288 Interest expense 515 483 1,533 1,447 Losses (gains) on sales of facilities 4 ( 2 ) ( 209 ) 12 15,581 14,583 45,928 42,304 Income before income taxes 1,906 1,630 6,390 5,361 Provision for income taxes 424 355 1,419 1,131 Net income 1,482 1,275 4,971 4,230 Net income attributable to noncontrolling interests 212 196 649 595 Net income attributable to HCA Healthcare, Inc. $ 1,270 $ 1,079 $ 4,322 $ 3,635 Per share data: Basic earnings $ 4.94 $ 3.98 $ 16.57 $ 13.26 Diluted earnings $ 4.88 $ 3.91 $ 16.37 $ 13.07 Shares used in earnings per share calculations (in millions): Basic 256.763 271.173 260.770 274.171 Diluted 259.917 275.424 263.987 278.173 The accompanying notes are an integral part of the condensed consolidated financial statements. 3 HCA HEALTHCARE, INC. CONDENSED CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS FOR THE QUARTERS AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023 Unaudited (Dollars in millions) Quarter Nine Months 2024 2023 2024 2023 Net income $ 1,482 $ 1,275 $ 4,971 $ 4,230 Other comprehensive income (loss) before taxes: Foreign currency translation 55 ( 35 ) 48 3 Unrealized gains (losses) on available-for-sale securitie